Cannabis does not improve breathlessness during exercise in patients with advanced COPD, conclude KPE, PATH researchers
Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD), according to a randomized controlled trial
The study, "Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced COPD: A Randomized Controlled Trial," was led by Sara Abdallah, PhD candidate in exercise physiology with our Department of Kinesiology and Physical Education (KPE). Co-authors included KPE professorÌýDennis Jensen, Director of the ±«ÓãÖ±²¥ Research Centre for Physical Activity and Health (PATH); (PATH), (PATH), and Michelle Moore (KPE student).
"Senior study author Dennis Jensen, PhD, associate professor of kinesiology and physical education and a scientist in the Translational Research in Respiratory Diseases Program at ±«ÓãÖ±²¥, said that trial results may not be generalizable because the number of participants was small and represented a relatively homogenous group of patients with stable, but advanced, COPD," wrote the report published by the American Thoracic Society in part. Numerous media outlets picked up the story including:
To read the study,Ìýpublished July 27Ìýin
Ìý
Ìý
